CSIMarket



Kymera Therapeutics Inc.  (KYMR)
Other Ticker:  
 
 

KYMR's Operating Income Growth by Quarter and Year

Kymera Therapeutics's Operating Income results by quarter and year




KYMR Operating Income (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -28.64 -8.08 0.00
III Quarter September - -24.73 0.00 0.00
II Quarter June -40.81 -13.17 0.00 0.00
I Quarter March -36.93 8.08 0.00 0.00
FY   -77.74 -58.46 -8.08 -



KYMR Operating Income second quarter 2022 Y/Y Growth Comment
Kymera Therapeutics Inc. in the second quarter 2022 recorded Operating Loss of $ -40.81 millions.

According to the results reported in the second quarter 2022, Kymera Therapeutics Inc. achieved the best Operating Income growth in Biotechnology & Pharmaceuticals industry. While Kymera Therapeutics Inc.' s Operating Income no change of % ranks overall at the positon no. in the second quarter 2022.

Explain Operating Income growth


KYMR Operating Income ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Kymera Therapeutics's second quarter 2022 Operating Income $ -40.81 millions KYMR's Income Statement
Kymera Therapeutics's second quarter 2021 Operating Income $ -13.17 millions Quarterly KYMR's Income Statement
New: More KYMR's historic Operating Income Growth >>


KYMR Operating Income (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income second quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Kymera Therapeutics's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KYMR's II. Quarter Q/Q Operating Income Comment
Recent results of -40.81 millions by Kymera Therapeutics Inc. look even worse if you take a look at -36.93 millions in the first quarter.

Within Biotechnology & Pharmaceuticals industry Kymera Therapeutics Inc. achieved highest sequential Operating Income growth. While Kymera Therapeutics's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


KYMR's II. Quarter Q/Q Operating Income Comment
Recent accomplishment of -40.81 millions by Kymera Therapeutics Inc. look even worse considering the -36.93 millions in the previous quarter.

Within Biotechnology & Pharmaceuticals industry Kymera Therapeutics Inc. achieved highest sequential Operating Income growth. While Kymera Therapeutics's Operating Income growth quarter on quarter, overall rank is .


Kymera Therapeutics's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Sep 30 2021)
12 Months Ending
(Jun 30 2021)
12 Months Ending
(Mar 31 2021)
Cumulative Operating Income 12 Months Ending $ -131.11 $ -103.47 $ -58.45 $ -37.90 $ 0.00
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Kymera Therapeutics Inc.' has realized cumulative trailing twelve months Operating Loss of $ -131 millions in the Jun 30 2022 period.
The results are worsening as the cumulative Operating Loss is getting bigger from $ -103.47 millions in TTM ending quarter Mar 31 2022 and $ -36.93 millions for the twelve months ending in the quarter Mar 31 2021.

Kymera Therapeutics Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Kymera Therapeutics Inc.' has realized cumulative trailing twelve months Operating Loss of $ -131 millions in the Jun 30 2022 period.
The results are getting worse as the cumulative Operating Loss is becoming larger from $ -103.47 millions in TTM ending quarter Mar 31 2022 and $ -36.93 millions for the twelve months ending in the quarter Mar 31 2021.

Kymera Therapeutics Inc. achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Biotechnology & Pharmaceuticals Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
KYMR's Operating Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for KYMR's Competitors
Operating Income Growth for Kymera Therapeutics's Suppliers
Operating Income Growth for KYMR's Customers

You may also want to know
KYMR's Annual Growth Rates KYMR's Profitability Ratios KYMR's Asset Turnover Ratio KYMR's Dividend Growth
KYMR's Roe KYMR's Valuation Ratios KYMR's Financial Strength Ratios KYMR's Dividend Payout Ratio
KYMR's Roa KYMR's Inventory Turnover Ratio KYMR's Growth Rates KYMR's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Jun 30 2022 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Jun 30 2022
Biomarin Pharmaceutical Inc235.44%$ 235.435 millions
Nuvasive Inc207.75%$ 207.752 millions
Merck and Co. Inc.205.14%$ 205.143 millions
Healthcare Services Group Inc.195.54%$ 195.539 millions
Lftd Partners Inc.184.44%$ 184.437 millions
Merit Medical Systems Inc161.45%$ 161.450 millions
Amphastar Pharmaceuticals Inc.135.07%$ 135.066 millions
Iradimed Corporation125.93%$ 125.926 millions
American Shared Hospital Services125.28%$ 125.284 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LTRN's Profile

Stock Price

LTRN's Financials

Business Description

Fundamentals

Charts & Quotes

LTRN's News

Suppliers

LTRN's Competitors

Customers & Markets

Economic Indicators

LTRN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071